Trials / Conditions / Hematologic and Lymphocytic Disorder

Hematologic and Lymphocytic Disorder

10 registered clinical trials studyying Hematologic and Lymphocytic Disorder — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Suspended	Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With NCT05993611	City of Hope Medical Center	Phase 1
Active Not Recruiting	Itacitinib for the Prevention of Graft Versus Host Disease NCT04859946	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Tra NCT04572815	Fred Hutchinson Cancer Center	Phase 2
Completed	Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplas NCT04339101	City of Hope Medical Center	Phase 2
Withdrawn	Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantat NCT04127721	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission NCT04062266	M.D. Anderson Cancer Center	Phase 2
Completed	Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients NCT03895918	Roswell Park Cancer Institute	N/A
Terminated	Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelate NCT03246906	Fred Hutchinson Cancer Center	Phase 2
Terminated	Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia NCT03195010	Fred Hutchinson Cancer Center	Phase 2
Recruiting	Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers NCT03207854	University of Southern California	—